Picture of Gritstone bio logo

GRTSQ — Gritstone bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: HHS Project Nextgen Selects Initial Vaccine Candidates And Awards Over $500 Million To Advance Development Of Vaccines And Therapeutics

Oct 13 (Reuters) - Gritstone bio Inc  GRTS.O :
    * HHS: PROJECT NEXTGEN SELECTS INITIAL VACCINE CANDIDATES
AND
AWARDS OVER $500 MILLION TO ADVANCE DEVELOPMENT OF VACCINES AND
THERAPEUTICS
    * HHS: VACCINE SELECTION BRINGS PRODUCTS CLOSER TO CLINICAL
TRIALS
SLATED TO BEGIN AS EARLY AS THIS WINTER

Source text for Eikon:  ID: 
Further company coverage:  GRTS.O 

 ((Reuters.Briefs@thomsonreuters.com ;))

Recent news on Gritstone bio

See all news